- Home
- ABEO vs JRS Comparison
ABEO vs JRS Comparison
Compare ABEO & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- JRS
- Stock Information
- Founded
- ABEO N/A
- JRS 2001
- Country
- ABEO United States
- JRS United States
- Employees
- ABEO N/A
- JRS N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- JRS Finance/Investors Services
- Sector
- ABEO Health Care
- JRS Finance
- Exchange
- ABEO Nasdaq
- JRS Nasdaq
- Market Cap
- ABEO 237.4M
- JRS 236.9M
- IPO Year
- ABEO 1980
- JRS N/A
- Fundamental
- Price
- ABEO $4.68
- JRS $8.30
- Analyst Decision
- ABEO Strong Buy
- JRS
- Analyst Count
- ABEO 5
- JRS 0
- Target Price
- ABEO $17.00
- JRS N/A
- AVG Volume (30 Days)
- ABEO 503.6K
- JRS 86.6K
- Earning Date
- ABEO 03-20-2025
- JRS 01-01-0001
- Dividend Yield
- ABEO N/A
- JRS 8.87%
- EPS Growth
- ABEO N/A
- JRS N/A
- EPS
- ABEO N/A
- JRS N/A
- Revenue
- ABEO N/A
- JRS N/A
- Revenue This Year
- ABEO N/A
- JRS N/A
- Revenue Next Year
- ABEO $561.86
- JRS N/A
- P/E Ratio
- ABEO N/A
- JRS N/A
- Revenue Growth
- ABEO N/A
- JRS N/A
- 52 Week Low
- ABEO $3.05
- JRS $5.95
- 52 Week High
- ABEO $8.45
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- ABEO 36.32
- JRS 47.85
- Support Level
- ABEO $4.42
- JRS $8.04
- Resistance Level
- ABEO $5.14
- JRS $8.21
- Average True Range (ATR)
- ABEO 0.25
- JRS 0.10
- MACD
- ABEO -0.05
- JRS 0.02
- Stochastic Oscillator
- ABEO 25.24
- JRS 92.86
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies. At least 75% of the Fund's managed assets will be in securities rated investment grade.